Prolongation of discordant cardiac xenotransplantation survival by Lisofylline, a phosphatidic acid inhibitor.
Aziz
S
S
Department of Surgery, University of Washington, Seattle 98195, USA.
Suzuki
K
K
Rice
G
G
Reichenbach
D D
DD
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000704:Analysis of Variance; D000818:Animals; D006085:Graft Survival / Q000187:drug effects / Q000502:physiology*; D006168:Guinea Pigs; D016027:Heart Transplantation / Q000473:pathology / Q000502:physiology*; D008297:Male; D010431:Pentoxifylline / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010712:Phosphatidic Acids / Q000037:antagonists & inhibitors; D051381:Rats; D011917:Rats, Inbred Lew; D013997:Time Factors; D014183:Transplantation, Heterologous / Q000473:pathology / Q000502:physiology*
D000276:Adjuvants, Immunologic; D010712:Phosphatidic Acids; C025189:lisofylline; D010431:Pentoxifylline